Please use this identifier to cite or link to this item:
Noninvasive Electromagnetic Sensors for Continuous Monitoring of Human Vital Signs and Assessment of Lung Fluid Content
|2016-05-phd-perron_r.pdf||Version for non-UH users. Copying/Printing is not permitted||12.58 MB||Adobe PDF||View/Open|
|2016-05-phd-perron_uh.pdf||For UH users only||12.58 MB||Adobe PDF||View/Open|
|Title:||Noninvasive Electromagnetic Sensors for Continuous Monitoring of Human Vital Signs and Assessment of Lung Fluid Content|
|Issue Date:||May 2016|
|Publisher:||[Honolulu] : [University of Hawaii at Manoa], [May 2016]|
|Abstract:||Early detection and continuous assessment of lung fluid content or abnormal fluid buildup in the lungs, is the foundation to the management and treatment of life threatening diseases such as heart failure (HF), and other cardiopulmonary related illnesses. However, available modalities are either invasive and/or not suitable for continuous monitoring. The Cardiopulmonary Stethoscope (CPS) system, aims to address this need. The CPS system is a noninvasive, portable, low-cost device, capable of monitoring vital signs (VS) such as heart rate (HR), respiratory rate (RR), and most importantly, detect changes in lung fluid content. This study is related to the development of the system and its use in clinical trials. Contributions of this dissertation included the following: (1) A textile based sensor for remote monitoring and wearable applications was developed and clinically validated for HR and RR measurements on healthy patients. (2) Specific Absorption Rate (SAR) measurements were conducted eith the DASY4 system using safety compliance guidelines set forth by the FCC. With 32 mW input power, the measured SAR was 0.4 W/kg which is only 1/4th of the FCC limit of 1.6 W/kg for 1g avg. (3) HR and RR measurements were clinically validated on seven healthy participants at rest and during exercise. Measured differences between the CPS device and standard hemodynamic devices were all within the limits of agreement, which were calculated using Bland-Altman analysis. (4) In collaboration with the Queen's Medical Center, sensitivity to changes in lung fluid content was also clinically validated with thirteen heart failure (HF) and eight hemodialysis (HD) patients. Polynomial regression fit of the overall changes in phase was generally in good agreement with the trend of the pulmonary arterial pressure measurements from the HF patients and fluid removed during hemodialysis treatment. HR and RR measurements also showed strong correlation (Pearson — Heart rate (HF): r = 0.79, p<0.05, (HD): r = 0.85, p<0.05; Respiratory rate (HF): r = 0.71, p<0.05, (HD): r = 0.42, p<0.05). (5) Simulation and experimental results have shown that sensor placement need to be considered in evaluating tradeoffs between monitoring vital signs and enhancing sensitivity to changes in lung fluid content.|
|Description:||Ph.D. University of Hawaii at Manoa 2016.|
Includes bibliographical references.
|Appears in Collections:||Ph.D. - Electrical Engineering|
Please contact firstname.lastname@example.org if you need this content in an alternative format.
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.